XML 35 R16.htm IDEA: XBRL DOCUMENT v3.5.0.1
10. SEGMENTS
12 Months Ended
Mar. 31, 2016
Segment Reporting [Abstract]  
SEGMENTS

We operate our businesses principally through two reportable segments: Aethlon, which represents our therapeutic business activities, and ESI, which represents our diagnostic business activities. Our reportable segments have been determined based on the nature of the potential products being developed. We record discrete financial information for ESI and our chief operating decision maker reviews ESI’s operating results in order to make decisions about resources to be allocated to the ESI segment and to assess its performance.

 

Aethlon’s revenue is generated primarily from government contracts to date and ESI does not yet have any revenues. We have not included any allocation of corporate overhead to the ESI segment.

  

The following tables set forth certain information regarding our segments:

 

   Fiscal Years Ended March 31, 
   2016   2015 
Revenues:          
Aethlon  $886,572   $762,417 
ESI        
Total Revenues  $886,572   $762,417 
           
Operating Losses:          
Aethlon  $(3,953,402)  $(3,081,169)
ESI   (431,432)   (911,684)
Total Operating Loss  $(4,384,834)  $(3,992,853)
           
Net Losses:          
Aethlon  $(4,527,184)  $(6,067,810)
ESI   (431,432)   (911,684)
Net Loss Before Non-Controlling Interests  $(4,958,616)  $(6,979,494)
           
Cash:          
Aethlon  $2,114,285   $721,689 
ESI   9,452    133,907 
Total Cash  $2,123,737   $855,596 
           
Total Assets:          
Aethlon  $2,503,327   $1,159,910 
ESI   53,430    220,678 
Total Assets  $2,556,757   $1,380,588 
           
Capital Expenditures:          
Aethlon  $9,307   $ 
ESI        
Capital Expenditures  $9,307   $ 
           
Depreciation and Amortization:          
Aethlon  $18,943   $17,770 
ESI   19,581    19,582 
Total Depreciation and Amortization  $38,524   $37,352 
           
Interest Expense:          
Aethlon  $573,782   $349,923 
ESI        
Total Interest Expense  $573,782   $349,923